Picard Medical Statistics
Total Valuation
Picard Medical has a market cap or net worth of $7.48 million. The enterprise value is $10.63 million.
| Market Cap | 7.48M |
| Enterprise Value | 10.63M |
Important Dates
The next estimated earnings date is Monday, September 14, 2026, before market open.
| Earnings Date | Sep 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Picard Medical has 2.05 million shares outstanding. The number of shares has increased by 564.93% in one year.
| Current Share Class | 2.05M |
| Shares Outstanding | 2.05M |
| Shares Change (YoY) | +564.93% |
| Shares Change (QoQ) | +1.00% |
| Owned by Insiders (%) | 5.14% |
| Owned by Institutions (%) | 4.58% |
| Float | 997,003 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.37 |
| Forward PS | 1.35 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75
| Current Ratio | 0.75 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -78.30% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 1,009.17% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $72,933 |
| Profits Per Employee | -$377,027 |
| Employee Count | 75 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0.65 |
Taxes
In the past 12 months, Picard Medical has paid $4,000 in taxes.
| Income Tax | 4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 8.24 |
| 200-Day Moving Average | 85.67 |
| Relative Strength Index (RSI) | 31.93 |
| Average Volume (20 Days) | 671,342 |
Short Selling Information
The latest short interest is 307,956, so 14.99% of the outstanding shares have been sold short.
| Short Interest | 307,956 |
| Short Previous Month | 60,568 |
| Short % of Shares Out | 14.99% |
| Short % of Float | 30.89% |
| Short Ratio (days to cover) | 0.53 |
Income Statement
In the last 12 months, Picard Medical had revenue of $5.47 million and -$28.28 million in losses. Loss per share was -$26.75.
| Revenue | 5.47M |
| Gross Profit | 429,000 |
| Operating Income | -14.52M |
| Pretax Income | -29.05M |
| Net Income | -28.28M |
| EBITDA | -14.36M |
| EBIT | -14.52M |
| Loss Per Share | -$26.75 |
Balance Sheet
The company has $121,000 in cash and $3.27 million in debt, with a net cash position of -$3.15 million or -$1.54 per share.
| Cash & Cash Equivalents | 121,000 |
| Total Debt | 3.27M |
| Net Cash | -3.15M |
| Net Cash Per Share | -$1.54 |
| Equity (Book Value) | -1.45M |
| Book Value Per Share | -0.96 |
| Working Capital | -3.15M |
Cash Flow
In the last 12 months, operating cash flow was -$17.23 million and capital expenditures -$26,000, giving a free cash flow of -$17.26 million.
| Operating Cash Flow | -17.23M |
| Capital Expenditures | -26,000 |
| Depreciation & Amortization | 167,000 |
| Net Borrowing | 1.22M |
| Free Cash Flow | -17.26M |
| FCF Per Share | -$8.40 |
Margins
| Gross Margin | 7.84% |
| Operating Margin | -265.48% |
| Pretax Margin | -531.13% |
| Profit Margin | n/a |
| EBITDA Margin | -262.10% |
| EBIT Margin | -265.15% |
| FCF Margin | n/a |
Dividends & Yields
Picard Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -564.93% |
| Shareholder Yield | -564.93% |
| Earnings Yield | -378.22% |
| FCF Yield | -230.84% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 3, 2026. It was a reverse split with a ratio of 1:50.
| Last Split Date | Aug 3, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
Picard Medical has an Altman Z-Score of -1.75 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.75 |
| Piotroski F-Score | 4 |